Ingalill Avis

2.1k citations

42 papers · 1.8k indexed · h-index 19

Impact in

Cancer Research top 5%
Pharmacology top 5%
- Inflammatory mediators and NSAID effects

Papers in

Oncology 17
- Lung Cancer Research Studies 9
- Peptidase Inhibition and Analysis 4
Toxicology 2

Co-authors: James L. Mulshine Anthony M. Treston Alfredo Martı́nez Michele D. Vos Frank Cuttitta Terry W. Moody Sung Hyeok Hong Marti Jett
Journals: Clinical Cancer Research (2 papers)Journal of Cellular Biochemistry (2 papers)Journal of Clinical Investigation (2 papers)American Journal of Respiratory Cell and Molecular Biology (2 papers)Environmental Health Perspectives (2 papers)
Partner nations: United States Spain India

In The Last Decade

Ingalill Avis

41 papers receiving 1.7k citations

Peers

Countries citing papers authored by Ingalill Avis

Since Specialization

Citations

This map shows the geographic impact of Ingalill Avis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingalill Avis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingalill Avis more than expected).

Fields of papers citing papers by Ingalill Avis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingalill Avis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingalill Avis. The network helps show where Ingalill Avis may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingalill Avis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingalill Avis Line = papers co-authored together Ingalill Avis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy Journal of Cancer ·Changge Fang, Ingalill Avis, David S. Salomon, Frank Cuttitta	2013	13
2	Non-Peptide Small Molecule Regulators of Lymphangiogenesis Lymphatic Research and Biology ·Changge Fang, Catherine Mcnestry, Ingalill Avis, Alfredo Martı́nez, Enrique Zudaire, Frank Cuttitta	2009	6
3	Ingenuity Network-Assisted Transcription Profiling: Identification of a New Pharmacologic Mechanism for MK886 Clinical Cancer Research ·Bilkisu Yakubu Indabo, Min Pu, Arjun Silverberg, Huaitian Liu, Joanna H. Shih, Srilatha Darsi, Ingalill Avis, James L. Mulshine	2006	76
4	Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer Breast Cancer Research and Treatment ·Jun Zhou, D. Craig Allred, Ingalill Avis, Alfredo Martı́nez, Michele D. Vos, Leia M. Smith, Anthony M. Treston, James L. Mulshine	2001	92
5	Recent molecular advances in the approach to early lung cancer detection and intervention. Environmental Health Perspectives ·James L. Mulshine, Frank Scott, Jinrun Zhou, Ingalill Avis, Michele D. Vos, Anthony M. Treston	1997	3
6	Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. Journal of Clinical Investigation ·Ingalill Avis, Marti Jett, Alvaro Erik Cala Pulido, Michele D. Vos, Terry W. Moody, Anthony M. Treston, Alfredo Martı́nez, James L. Mulshine	1996	216
7	Peptide amidating activity in human bronchoalveolar lavage fluid Lung Cancer ·Frank Scott, Anthony M. Treston, Gail L. Shaw, Ingalill Avis, Lisiane Amaral De Pinho, Karen Kelly, Edward C. Dempsey, Alan Cantor, Melvyn S. Tockman, James L. Mulshine	1996	7
8	Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage Journal of Cellular Biochemistry ·Frank Scott, Frank Cuttitta, Anthony M. Treston, Ingalill Avis, Prabodh K. Gupta, John C. Ruckdeschel, Karen Kelly, Steven Piantadosi, Melvyn S. Tockman, James L. Mulshine	1993	12
9	Effect of gastrin‐releasing peptide on the pancreatic tumor cell line (capan) Molecular Carcinogenesis ·Ingalill Avis, Frank Cuttitta, Anthony M. Treston, James L. Mulshine, Marti Jett, Philip G. Kasprzyk, Rhoda Maneckjee	1993	16
10	Scientific basis for cancer prevention intermediate cancer markers Cancer ·James L. Mulshine, Marti Jett, Frank Cuttitta, Anthony M. Treston, Kathryn Quinn, Frank Scott, Shatakshi Tiwari, Ingalill Avis, R. Ilona Linnoila, Gail L. Shaw	1993	14
11	Growth Factors and Other Targets for Rational Application as Intervention Agents Advances in experimental medicine and biology ·James L. Mulshine, Michael J. Birrer, Anthony M. Treston, Frank Scott, Kathryn Quinn, Ingalill Avis, Frank Cuttitta	1992	4
12	Candidate biomarkers for applications as intermediate end points of lung carcinogenesis Journal of Cellular Biochemistry ·James L. Mulshine, A. K. Nandi, Juan Pablo Jiménez Moreno, Frank Scott, Kathryn Quinn, Ingalill Avis, Gail L. Shaw, Sandra Jensen, G. O. Okikiolu, Michael J. Birrer, Frank Cuttitta	1992	2
13	[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. PubMed ·Soliman A. Mahmoud, Julie K. Staley, John E. Taylor, Arthur E. Bogdén, J P Moreau, D.H. Coy, Ingalill Avis, Frank Cuttitta, James L. Mulshine, Terry W. Moody	1991	140
14	Autocrine Growth Factors as Therapeutic Targets in Lung Cancer CHEST Journal ·James L. Mulshine, Anthony M. Treston, Ronald B. Natale, Philip G. Kasprzyk, Ingalill Avis, Yoichi Nakanishi, Frank Cuttitta	1989	6
15	Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation Analytical Biochemistry ·Philip G. Kasprzyk, G. N. Gao, Ingalill Avis, Yoichi Nakanishi, Anthony M. Treston, Helen Wong, John H. Walsh, James L. Mulshine	1988	11
16	Growth Factor Effects on Small Cell Lung Cancer Cells Using a Colorimetric Assay: Can a Transferrin-Like Factor Mediate Autocrine Growth? Pathobiology ·Yoichi Nakanishi, G. N. Gao, Philip G. Kasprzyk, Ingalill Avis, مناحي بن خنثل بن جربوع القحطاني, Adi F. Gazdar, James L. Mulshine	1988	21
17	Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancer^a,^b Annals of the New York Academy of Sciences ·James L. Mulshine, Ingalill Avis, Anthony M. Treston, Eduardo Gardella, A Stanguennec, Jorge A. Carrasquillo, Steven M. Larson, Yoichi Nakanishi, Bruce Merchant, John D. Minna, Frank Cuttitta	1988	31
18	Consideration of the Chemistry of Solid‐Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptides^a,^b Annals of the New York Academy of Sciences ·Philip G. Kasprzyk, Frank Cuttitta, Anthony M. Treston, Ingalill Avis, Yoichi Nakanishi, Helen Wong, John H. Walsh, James L. Mulshine	1988	3
19	Antigenic Cross-Reactivity Between Adenocarcinoma of the Breast and Fibrocystic Disease of the Breast 2 JNCI Journal of the National Cancer Institute ·Laura Owczarek, Ingalill Avis, James F. Newsome, Geoffrey Haughton	1976	13
20	Antigenic cross reactivity between benign prostatic hyperplasia and adenocarcinoma of prostate Urology ·Laura Owczarek, Ingalill Avis, A.T. Cole, Floyd A. Fried, Geoffrey Haughton	1975	28

About Ingalill Avis

Ingalill Avis is a scholar working on Oncology, Toxicology, Pharmacology, Molecular Biology and Cancer Research, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), RNA modifications and cancer (6 papers), Inflammatory mediators and NSAID effects (6 papers), Glycosylation and Glycoproteins Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Neuropeptides and Animal Physiology (4 papers), Estrogen and related hormone effects (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (323 citations), Pharmacology (320 citations), Biochemistry (130 citations), Oncology (425 citations) and Molecular Biology (911 citations). Ingalill Avis has collaborated with scholars based in United States, Spain and India. Frequent co-authors include James L. Mulshine, Anthony M. Treston, Alfredo Martı́nez, Michele D. Vos, Frank Cuttitta, Terry W. Moody, Sung Hyeok Hong, Marti Jett, Jun Zhou and Philip G. Kasprzyk. Their work appears in journals such as Clinical Cancer Research, Journal of Cellular Biochemistry, Journal of Clinical Investigation, American Journal of Respiratory Cell and Molecular Biology and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact